Merck, CAPVAXIVE and conjugate vaccine
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
Hosted on MSN7mon
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infectionsPfizer's single-dose pneumococcal vaccine, Prevnar 20, is the current leader in the market for adults. But Merck expects its new shot to capture the majority of market share among adults ...
Merck (MRK) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, recommended ...
Merck already sells an older pneumococcal vaccine called Pneumovax 23, which protects against 23 strains but is a polysaccharide based shot, so doesn't stimulate as strong an immune response as ...
The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...
If confirmed as health secretary, Robert F. Kennedy Jr. would oversee the Food and Drug Administration and other agencies ...
Robert F. Kennedy Jr., who awaits confirmation as Donald Trump's Health and Human Services secretary, helped organize mass ...
Pfizer and Merck have each won FDA approvals in the past year for new pneumococcal vaccines, but GSK aims to top both of them with its $2.1 billion acquisition of Affinivax. That biotech’s Phase ...
One line of questioning that senators might pursue are the legal payments that Robert F. Kennedy Jr. received in recent years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback